You are here

  • Home
  • Archive
  • Volume 97, Issue 4
  • Author's response to Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Author's response to Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials

https://doi.org/10.1136/bjophthalmol-2012-302954

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors Sole author.

    • Funding Received research support from Bausch&Lomb, Fluoron GmbH and Alamedics GmbH.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval University of Cologne.

    Linked Articles